Focus: Asia Pacific
- Can Chinese Phase I data from the West accelerate China drug development? The science of ethnobridging
- Industry's experience on ACSS regulatory worksharing pilot
- Reliability standards for Japanese marketing approval applications
- Fixed-dose combination products – the regulatory landscape in the US, the EU and its evolution in India
- Advertising cosmetics versus medicines: a comparative analysis across markets
- Advanced therapies and regenerative medicines regulation – part II: the US
- A review of IDMP and SPOR data management services
Use the issue archive below to download the complete February 2020 issue as a PDF or to access individual articles or complete issues going back to 2015.
Note: To access members-only content, you must be logged in to the site with your TOPRA Member account.